loadpatents
name:-0.021317005157471
name:-0.013551950454712
name:-0.00049591064453125
Lee; Kyungae Patent Filings

Lee; Kyungae

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lee; Kyungae.The latest application filed is for "small molecule inhibitors of ebola and lassa fever viruses and methods of use".

Company Profile
0.23.26
  • Lee; Kyungae - Allston MA
  • Lee; Kyungae - Newton MA
  • Lee; Kyungae - Guilford CT
  • Lee; Kyungae - Chungnam KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Small Molecule Inhibitors Of Ebola And Lassa Fever Viruses And Methods Of Use
App 20210163454 - Cunningham; James ;   et al.
2021-06-03
Method of treating Ebola
Grant 9,676,763 - Cunningham , et al. June 13, 2
2017-06-13
Small molecule inhibitors of ebola and lassa fever viruses
Grant 9,452,992 - Cunningham , et al. September 27, 2
2016-09-27
Type III secretion inhibitors, analogs and uses thereof
Grant 9,340,505 - Goguen , et al. May 17, 2
2016-05-17
Small Molecule Inhibitors of Ebola and Lassa Fever Viruses and Methods of Use
App 20160024066 - Cunningham; James ;   et al.
2016-01-28
Small molecule inhibitors of ebola and lassa fever viruses and methods of use
Grant 9,193,705 - Cunningham , et al. November 24, 2
2015-11-24
Small Molecule Inhibitors of Ebola and Lassa Fever Viruses
App 20140329834 - Cunningham; James ;   et al.
2014-11-06
Type Iii Secretion Inhibitors, Analogs And Uses Thereof
App 20140323483 - Goguen; Jon ;   et al.
2014-10-30
Type III secretion inhibitors, analogs and uses thereof
Grant 8,716,283 - Goguen , et al. May 6, 2
2014-05-06
Methods and compounds for antimicrobial intervention
Grant 8,598,342 - Kahne , et al. December 3, 2
2013-12-03
Small Molecule Inhibitors Of Ebola And Lassa Fever Viruses And Methods Of Use
App 20130231332 - Cunningham; James ;   et al.
2013-09-05
3-aryl-5,6-disubstituted pyridazines
Grant 8,338,591 - Yoon , et al. December 25, 2
2012-12-25
Methods And Compounds For Antimicrobial Intervention
App 20120046282 - Kahne; Suzanne Walker ;   et al.
2012-02-23
3-substituted-6-aryl Pyridines
App 20110281837 - Hutchinson; Alan J. ;   et al.
2011-11-17
3-aryl-5,6-disubstituted pyridazines
App 20110160187 - Yoon; Taeyoung ;   et al.
2011-06-30
1-aryl-4-substituted isoquinolines
Grant 7,915,288 - Lee , et al. March 29, 2
2011-03-29
Type Iii Secretion Inhibitors, Analogs And Uses Thereof
App 20110034463 - Goguen; Jon ;   et al.
2011-02-10
3-substituted-6-aryl pyridines
Grant 7,863,454 - Hutchison , et al. January 4, 2
2011-01-04
Benzimidazole and Pyridylimidazole Derivatives
App 20100267698 - Li; Guiying ;   et al.
2010-10-21
Benzimidazole and pyridylimidazole derivatives
Grant 7,642,267 - Li , et al. January 5, 2
2010-01-05
3-Substituted-6-Aryl Pyridines
App 20090176980 - Hutchison; Alan J. ;   et al.
2009-07-09
Benzimidazole and Pyridylimidazole Derivatives
App 20080227793 - Li; Guiying ;   et al.
2008-09-18
Monoclonal antibody specific for PPAR gamma, hydridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same
Grant 7,387,895 - Yoon , et al. June 17, 2
2008-06-17
3-substituted-6-aryl pyridines
Grant 7,342,115 - Hutchison , et al. March 11, 2
2008-03-11
Benzimidazole and pyridylimidazole derivatives
Grant 7,300,945 - Li , et al. November 27, 2
2007-11-27
1-aryl-4-substituted isoquinolines
App 20070249665 - Lee; Kyungae
2007-10-25
Substituted 1-Benzyl-4-Substituted Piperazine Analogues
App 20070249616 - Hutchison; Alan J. ;   et al.
2007-10-25
Substituted 1-benzyl-4-substituted piperazine analogues
Grant 7,253,168 - Hutchison , et al. August 7, 2
2007-08-07
Substituted 1-benzyl-4-substituted piperazine analogues
App 20060142301 - Hutchison; Alan J. ;   et al.
2006-06-29
Monoclonal antibody specific for ppar gamma, hybridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same
App 20060140938 - Yoon; Doyoung ;   et al.
2006-06-29
Benzimidazole and pyridylimidazole derivatives
App 20060025425 - Li; Guiying ;   et al.
2006-02-02
Aryl-substituted piperazine derivatives
App 20060009456 - Hutchinson; Alan J. ;   et al.
2006-01-12
Heterocyclic compounds as ligands of the GABAA receptor
Grant 6,949,562 - Yohannes , et al. September 27, 2
2005-09-27
Benzimidazole and pyridylimidazole derivatives
Grant 6,916,819 - Li , et al. July 12, 2
2005-07-12
Substituted tetrahydroisoquinolines as C5a receptor modulators
Grant 6,916,830 - Lee , et al. July 12, 2
2005-07-12
Substituted tetrahydroisoquinolines as C5a receptor modulators
App 20040204446 - Lee, Kyungae ;   et al.
2004-10-14
Substituted tetrahydroisoquinolines as C5a receptor modulators
Grant 6,777,422 - Lee , et al. August 17, 2
2004-08-17
3-substituted-6-aryl pyridines
App 20040158067 - Hutchison, Alan J. ;   et al.
2004-08-12
Heterocyclic compounds as ligands of the GABAA receptor
App 20040110778 - Yohannes, Daniel ;   et al.
2004-06-10
Substituted tetrahydroisoquinolines as C5a receptor modulators
App 20040006069 - Lee, Kyungae ;   et al.
2004-01-08
Heterocyclic compounds as ligands of the GABAA receptor
Grant 6,653,471 - Yohannes , et al. November 25, 2
2003-11-25
Heterocyclic compounds as ligands of the GABAA receptor
App 20030105081 - Yohannes, Daniel ;   et al.
2003-06-05
Benzimidazole and pyridylimidazole derivatives
App 20030069257 - Li, Guiying ;   et al.
2003-04-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed